CHD1 and prostate cancer: This study proposes also the existence of at least two different molecular subtypes of prostate cancer: one characterized by the presence of ERG rearrangements and features of chromoplexy and the other one characterized by the absence of ERG rearrangements and CHD1 deletions, exhibiting intrachromosomal rearrangements and features of chromotripsis [72].